S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17

Organicell Regenerative Medicine (BPSR) Stock Forecast, Price & News

0.00 (-10.71%)
(As of 05/16/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
354,562 shs
Average Volume
3.31 million shs
Market Capitalization
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive BPSR News and Ratings via Email

Sign-up to receive the latest news and ratings for Organicell Regenerative Medicine and its competitors with MarketBeat's FREE daily newsletter.

About Organicell Regenerative Medicine

Biotech Products Services & Research, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development of biological therapeutics for the treatment of degenerative diseases and to provide other related services. The firm also focuses on processing, distribution and supply of biologically processed cellular and tissue-based products developed from internally based research and development activities and also provides healthcare, anti-aging, and regenerative services. The company was founded by John Goodhew, Albert Mitrani and Maria Ines Mitrani on August 9, 2011 and is headquartered in Miami, FL.


Organicell Regenerative Medicine, Inc. (BPSR)
See More Headlines

Industry, Sector and Symbol

Current Symbol
Year Founded

Sales & Book Value

Annual Sales


Pretax Margin




Free Float
Not Optionable


Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Organicell Regenerative Medicine (OTCMKTS:BPSR) Frequently Asked Questions

Who are Organicell Regenerative Medicine's key executives?
Organicell Regenerative Medicine's management team includes the following people:
What other stocks do shareholders of Organicell Regenerative Medicine own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Organicell Regenerative Medicine investors own include (XXII), Ciena (CIEN), Orbit Garant Drilling (OGD), Royal Caribbean Cruises (RCL), Synergy Pharmaceuticals (SGYP), Achillion Pharmaceuticals (ACHN), Aurora Cannabis (ACB), ACADIA Pharmaceuticals (ACAD), Arbutus Biopharma (ABUS) and Abacus Property Group (ABP).

What is Organicell Regenerative Medicine's stock symbol?

Organicell Regenerative Medicine trades on the OTCMKTS under the ticker symbol "BPSR."

How do I buy shares of Organicell Regenerative Medicine?

Shares of BPSR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Organicell Regenerative Medicine's stock price today?

One share of BPSR stock can currently be purchased for approximately $0.02.

How many employees does Organicell Regenerative Medicine have?

Organicell Regenerative Medicine employs 18 workers across the globe.

What is Organicell Regenerative Medicine's official website?

The official website for Organicell Regenerative Medicine is www.bespoketricycles.com.

How can I contact Organicell Regenerative Medicine?

Organicell Regenerative Medicine's mailing address is 4045 Sheridan Avenue,Suite 239, MIAMI, FL 33140, United States. The company can be reached via phone at (888) 963-7881.

This page was last updated on 5/18/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.